Peter Horak

Deputy Head of Department

UniversitätsKlinikum Heidelberg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Horak is the Deputy Head of Department at UniversitätsKlinikum Heidelberg, Germany. His research focuses on precision oncology, molecularly guided therapy, and the genomic landscape of various cancers, as evidenced by his recent publications. He has contributed significantly to the development of guidelines for molecular tumor boards and the evaluation of genomic test results in clinical practice.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (13)

Kilannin Krysiak

Assistant Professor

Washington University in St. Louis

UNITED STATES

View details

Susanna Kiwala

Washington University in St. Louis

UNITED STATES

View details

Sebastian Stintzing

Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

Marie Morfouace

Institut Gustave Roussy

FRANCE

View details

Arne Jahn

Technische Universität Dresden

GERMANY

View details

Chantal Pauli

Universität Zurich Medizinische Fakultät

SWITZERLAND

View details

Anna Czarnecka

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Patrick Metzger

GERMANY

View details

Tilman Brummer

University of Freiburg

GERMANY

View details

Manuela Benary

Charité - Universitätsmedizin Berlin

GERMANY

View details

Claudia Ball

Head Preclinical Model Unit

German Cancer Research Center (DKFZ)

GERMANY

View details

Ralph M. Fritsch

SWITZERLAND

View details

Joern Dengjel

Professor for Biochemistry and Cell Biology

University of Fribourg

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Horak

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma.

ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice.

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology.

The Progression-Free-Survival Ratio in Molecularly Aided Tumor Trials: A Critical Examination of Current Practice and Suggestions for Alternative Methods.

Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology.

ESMO Recommendations on clinical reporting of genomic test results for solid cancers.

[Precision oncology and molecular tumor boards].

Measuring Progress in Precision Oncology.

Measuring Progress in Precision Oncology

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Tumour mutational burden and survival with molecularly matched therapy

BRAF <sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology.

Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.

The German Network for Personalized Medicine to enhance patient care and translational research.

National Center for Tumor Diseases Precision Oncology Thesaurus for Drugs: A Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer Medicine.

National Center for Tumor Diseases Precision Oncology Thesaurus for Drugs: A Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer Medicine

Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study.

Collaborators (13)

Kilannin Krysiak

Susanna Kiwala

Sebastian Stintzing

Marie Morfouace

Arne Jahn

Chantal Pauli

Anna Czarnecka

Patrick Metzger

Tilman Brummer

Manuela Benary

Claudia Ball

Ralph M. Fritsch

Joern Dengjel

Make your next move.